InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
ANTX
Result 28 decisions over 120 months
Reset filters
Direction ?
Both105 Bought28 Sold77
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: ANTX Direction: Bought
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
ANTX AN2 Therapeutics, Inc.
1 Sep 2026
FitzPatrick Margaret M
Director
Bought
2,098
$11.60K
24.4%
ANTX AN2 Therapeutics, Inc.
2 Jun 2025
Easom Eric
Chief Executive Officer
Bought
10,000
$10.67K
4.1%
ANTX AN2 Therapeutics, Inc.
28 May 2025
FitzPatrick Margaret M
Director
Bought
8,610
$10.13K
opened
ANTX AN2 Therapeutics, Inc.
10 Dec 2024
Readnour Robin Shane
Director indirect
Bought 2×
10,000
$14.93K
1.6%
ANTX AN2 Therapeutics, Inc.
9 Dec 2024
Readnour Robin Shane
Director indirect
Bought 2×
30,772
$43.98K
5.0%
ANTX AN2 Therapeutics, Inc.
6 Dec 2024
Readnour Robin Shane
Director indirect
Bought 2×
19,228
$27.79K
3.2%
ANTX AN2 Therapeutics, Inc.
27 Nov 2024
Readnour Robin Shane
Director indirect
Bought 2×
50,000
$70.84K
8.7%
ANTX AN2 Therapeutics, Inc.
27 Nov 2024
Zakrzewski Joseph S
Director
Bought
2,000
$2.80K
1.6%
ANTX AN2 Therapeutics, Inc.
26 Nov 2024
Readnour Robin Shane
Director indirect
Bought 2×
25,000
$34.85K
4.4%
ANTX AN2 Therapeutics, Inc.
20 Nov 2024
Readnour Robin Shane
Director indirect
Bought 2×
50,000
$57.87K
9.3%
ANTX AN2 Therapeutics, Inc.
19 Nov 2024
Readnour Robin Shane
Director indirect
Bought 2×
150,000
$155.26K
36.6%
ANTX AN2 Therapeutics, Inc.
19 Nov 2024
Zakrzewski Joseph S
Director
Bought
5,000
$5.05K
4.2%
ANTX AN2 Therapeutics, Inc.
18 Nov 2024
Easom Eric
Chief Executive Officer indirect
Bought
50,000
$49.97K
4.9%
ANTX AN2 Therapeutics, Inc.
18 Nov 2024
Zakrzewski Joseph S
Director
Bought
20,000
$20.00K
20.4%
ANTX AN2 Therapeutics, Inc.
14 Aug 2024
Leonard Braden Michael
10% owner indirect
Bought
1,500,000
$1.56M
35.3%
ANTX AN2 Therapeutics, Inc.
18 Aug 2023
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
1,777,778
$16.00M
52.9%
ANTX AN2 Therapeutics, Inc.
15 May 2023
Easom Eric
Chief Executive Officer indirect
Bought
10,000
$53.77K
1.0%
ANTX AN2 Therapeutics, Inc.
4 Aug 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
100
$799.00
0.0%
ANTX AN2 Therapeutics, Inc.
3 Aug 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
1,809
$13.53K
0.0%
ANTX AN2 Therapeutics, Inc.
27 Jul 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
8,281
$65.50K
0.2%
ANTX AN2 Therapeutics, Inc.
26 Jul 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
14,938
$115.17K
0.4%
ANTX AN2 Therapeutics, Inc.
21 Jun 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
302
$2.41K
0.0%
ANTX AN2 Therapeutics, Inc.
14 Jun 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
61,424
$489.40K
1.7%
ANTX AN2 Therapeutics, Inc.
13 Jun 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
20,000
$158.00K
0.5%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought 2×
1,666,666
$25.00M
105%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
Aziz Kabeer
Director indirect
Bought
166,666
$2.50M
8.2%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
Adjuvant Global Health Technology Fund, L.P.
10% owner indirect
Bought
166,666
$2.50M
8.2%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
Readnour Robin Shane
Director indirect
Bought 2×
153,334
$2.30M
45.9%
Showing 1–28 of 28.